Developing and Evaluating Quality-Weighted Hospital-Free Days as a Novel, Patient-Centered Outcome for Trials of Patients with Acute Respiratory Failure
制定和评估质量加权的非住院日作为急性呼吸衰竭患者试验的一种新颖的、以患者为中心的结果
基本信息
- 批准号:10427764
- 负责人:
- 金额:$ 19.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-05 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAcute respiratory failureAdmission activityAdultAmericanCaregiver BurdenCaregiver researchCaregiversClinical TrialsCognitiveCohort StudiesConsensusCritical CareCritical IllnessDataData ReportingDevelopment PlansElectronic Health RecordEnrollmentEnvironmentFamilyFamily CaregiverFamily memberFinancial SupportFrequenciesFutureGoalsHealthHomeHospital MortalityHospitalsImpaired healthImpairmentIncidenceInstitutionIntensive Care UnitsInterdisciplinary StudyInternationalInterventionK-Series Research Career ProgramsKnowledgeLeadLungMeasurableMeasuresMentorsMethodologyMethodsModalityNational Heart, Lung, and Blood InstituteOutcomeOutcome MeasurePatient Outcomes AssessmentsPatient-Focused OutcomesPatientsPennsylvaniaPhysiciansPopulationPositioning AttributePropertyProspective StudiesProspective cohortProspective cohort studyPsychometricsPublic HealthQuality of lifeQuality-of-Life AssessmentRecordsReportingResearchResearch DesignResearch PersonnelSample SizeScholarshipScienceScientistStatistical ModelsStructureSurveysSurvivorsTechniquesTrainingTranslatingUniversitiesWeightWorkacute carecareercareer developmentcohortdesigndigitalexperiencefollow-upfunctional statushealth care service utilizationhealth goalshospital readmissionimprovedinnovationinstrumentmodels and simulationmortalitynovelpalliativepatient engagementpatient orientedprospectivepsychosocialrandomized trialrecruitresponseskillssocialsuccesssurvivorship
项目摘要
Project Summary/Abstract
Candidate: Catherine Auriemma, MD, is a pulmonary and critical care physician-scientist passionate about
understanding and improving long-term outcomes of patients with acute respiratory failure (ARF). To advance
her career towards research independence, she seeks didactic and experiential training to develop expertise in
consensus methods, prospective study design, and statistical modeling and simulation.
Research Context: Rising incidence and decreasing mortality of ARF has produced a growing population of
survivors facing significant physical, cognitive, and social impairments requiring increased healthcare
utilization. A crucial barrier to advancing ARF survivorship research is the lack of an outcome measure that is
patient-centered and appropriate for evaluating interventions with either palliative or restorative intent. Hospital-
free days (HFDs), the number of days spent alive and outside an acute care hospital, has become common in
studies of other acutely ill populations. However, HFDs does not account for decrements in functional status or
quality of life; and the bimodal distribution of HFDs among ARF patients raises questions regarding the
statistical power and construct validity of HFDs for ARF. This study proposes to design and evaluate a method
to quality-weight HFDs using patient-reported assessments of function, quality of life, or caregiver burden.
Specific Aims: 1) Develop an optimal approach to quality-weight HFDs using consensus methods with key
stakeholders; 2) Assess quality-weighted HFDs among a prospective cohort of ARF patients; 3) Compare
statistical power and construct validity of HFDs with and without quality-weighting in a large ARF cohort.
Research Plan: To accomplish these aims, Dr. Auriemma will convene a Delphi panel of ARF survivors, family
caregivers, clinicians, and trialists to develop best practices for integrating patient- and caregiver-reported data
into assessments of HFDs. She will then apply the novel method to a prospective cohort of ARF patients to
assess acceptability, responsiveness, and variability of quality-weighted HFDs. Finally, she will use observed
values in the Aim 2 cohort to simulate quality-weighted HFDs in a large clinical trial among patients with ARF to
compare statistical power and construct validity of unweighted and quality-weighted HFDs.
Career Development Plan: Working closely with her mentors and advisors, Dr. Auriemma will 1) develop
expertise in consensus methods necessary to convert multiple patient-identified core values into measurable
outcomes; 2) obtain the skills necessary to design, launch, oversee, and complete a multisite, prospective
cohort study; and 3) gain methodologic expertise in advanced statistical modeling and simulation techniques.
Environment: The University of Pennsylvania offers an ideal environment to pursue this training, with well-
established mentors and her home department heavily dedicated to Dr. Auriemma’s success, and several
multi-disciplinary research centers with long track records of producing successful, independent investigators.
项目总结/摘要
候选人:Catherine Auriemma,医学博士,是一位肺部和重症监护医生,科学家,热衷于
了解和改善急性呼吸衰竭(ARF)患者的长期结局。推进
她的职业生涯走向研究独立,她寻求教学和经验培训,以发展专业知识,
共识方法,前瞻性研究设计,统计建模和模拟。
研究背景:ARF发病率的上升和死亡率的下降使越来越多的人
幸存者面临严重的身体、认知和社会障碍,需要增加医疗保健
利用率推进ARF生存率研究的一个关键障碍是缺乏一种结果测量方法,
以患者为中心,适用于评估具有姑息或恢复意图的干预措施。医院-
自由日(HFD),即在急性护理医院外存活的天数,在美国已经很常见。
其他急性病患者的研究。然而,HFD不考虑功能状态的下降,
生活质量; ARF患者中HFD的双峰分布提出了关于
统计功效和结构效度。本研究提出设计和评估一种方法,
使用患者报告的功能、生活质量或护理者负担评估的质量加权HFD。
具体目标:1)使用关键的共识方法开发质量-重量HFD的最佳方法
利益相关者; 2)评估ARF患者前瞻性队列中的质量加权HFD; 3)比较
在一个大型ARF队列中,有和没有质量加权的HFD的统计功效和结构效度。
研究计划:为了实现这些目标,Auriemma博士将召集一个德尔菲小组,成员包括ARF幸存者、家庭成员和研究人员。
护理人员、临床医生和试验人员制定整合患者和患者报告数据的最佳实践
评估HFD。然后,她将把这种新方法应用于ARF患者的前瞻性队列,
评估质量加权HFD的可接受性、响应性和可变性。最后,她将使用观察
在ARF患者中进行的一项大型临床试验中,Aim 2队列中的数值模拟质量加权HFD,
比较未加权和质量加权HFD的统计功效和结构效度。
职业发展计划:奥里玛博士将与她的导师和顾问密切合作,
将多个患者确定的核心价值转化为可衡量的
成果; 2)获得设计,启动,监督和完成多站点,前瞻性
队列研究; 3)获得先进的统计建模和模拟技术的方法学专业知识。
环境:宾夕法尼亚大学提供了一个理想的环境,追求这种培训,以及-
建立导师和她的家庭部门严重致力于博士奥里玛的成功,和几个
多学科研究中心,长期以来培养出成功的独立研究人员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Catherine Louise Auriemma其他文献
Catherine Louise Auriemma的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Catherine Louise Auriemma', 18)}}的其他基金
Developing and Evaluating Quality-Weighted Hospital-Free Days as a Novel, Patient-Centered Outcome for Trials of Patients with Acute Respiratory Failure
制定和评估质量加权的非住院日作为急性呼吸衰竭患者试验的一种新颖的、以患者为中心的结果
- 批准号:
10676728 - 财政年份:2022
- 资助金额:
$ 19.37万 - 项目类别:
相似海外基金
Optimizing Time-Limited Trials of Mechanical Ventilation in Acute Respiratory Failure: A Mixed Methods Observational Study
优化急性呼吸衰竭机械通气的限时试验:混合方法观察研究
- 批准号:
10633823 - 财政年份:2023
- 资助金额:
$ 19.37万 - 项目类别:
Novel Digital Methods to Evaluate Functional and Pulmonary Outcomes following Pediatric Acute Respiratory Failure
评估小儿急性呼吸衰竭后功能和肺部结果的新型数字方法
- 批准号:
10724042 - 财政年份:2023
- 资助金额:
$ 19.37万 - 项目类别:
Use of Inter-Hospital Transfer Services in Critical Illness and Acute Respiratory Failure
在危重疾病和急性呼吸衰竭中使用医院间转运服务
- 批准号:
10739060 - 财政年份:2023
- 资助金额:
$ 19.37万 - 项目类别:
Strengthening implementation science in Acute Respiratory Failure using multilevel analysis of existing data
利用现有数据的多级分析加强急性呼吸衰竭的实施科学
- 批准号:
10731311 - 财政年份:2023
- 资助金额:
$ 19.37万 - 项目类别:
Identifying patient subgroups and processes of care that cause outcome differences following ICU vs. ward triage among patients with acute respiratory failure and sepsis
确定急性呼吸衰竭和脓毒症患者在 ICU 与病房分诊后导致结局差异的患者亚组和护理流程
- 批准号:
10734357 - 财政年份:2023
- 资助金额:
$ 19.37万 - 项目类别:
Health expectations after acute respiratory failure in survivor-care partner dyads
幸存者护理伙伴二人组急性呼吸衰竭后的健康期望
- 批准号:
10732929 - 财政年份:2023
- 资助金额:
$ 19.37万 - 项目类别:
Temporal trends in quality indicators of palliative care for patients with chronic illness hospitalized with acute respiratory failure
因急性呼吸衰竭住院的慢性病患者姑息治疗质量指标的时间趋势
- 批准号:
10622756 - 财政年份:2023
- 资助金额:
$ 19.37万 - 项目类别:
Financial Hardship among Patients with Acute Respiratory Failure and their Family Member Caregivers: Understanding the Impact on Patient- and Family- Centered Outcomes
急性呼吸衰竭患者及其家庭成员护理人员的经济困难:了解对以患者和家庭为中心的结果的影响
- 批准号:
10413457 - 财政年份:2022
- 资助金额:
$ 19.37万 - 项目类别:
Association of patient characteristics and antibiotic timing with the development of acute respiratory failure in hospital-acquired sepsis
患者特征和抗生素使用时机与医院获得性脓毒症急性呼吸衰竭发展的关系
- 批准号:
10313769 - 财政年份:2022
- 资助金额:
$ 19.37万 - 项目类别:














{{item.name}}会员




